The company focuses on using mesenchymal stem cells infused into a biological scaffold to treat meniscus degeneration. Their therapy aims to provide a regenerative medicine solution for tissue repair. NTL Biologica is at the forefront of developing innovative technology in the field of regenerative medicine and also produces autologous bone marrow concentrate kits.